Prelude Therapeutics, Inc. (PRLD)
3.23
-0.02
(-0.77%)
USD |
NASDAQ |
Nov 20, 16:00
3.22
-0.01
(-0.31%)
After-Hours: 20:00
Prelude Therapeutics Profit Margin (Quarterly) : -222.1% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -222.1% |
| June 30, 2026 | -244.1% |
| March 31, 2026 | -226.7% |
| December 31, 2025 | -291.8% |
| September 30, 2025 | -303.5% |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | -718.3% |
| September 30, 2024 | -1.08K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Q32 Bio, Inc. | -- |
| Intellia Therapeutics, Inc. | -1.78K% |
| Twist Bioscience Corp. | -16.28% |
| Beam Therapeutics, Inc. | -43.78K% |
| Revolution Medicines, Inc. | -206.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -59.87% |
| Return on Assets | -36.99% |
| Return on Invested Capital | -49.93% |
| Gross Profit Margin (Quarterly) | 93.96% |
| Operating Margin (Quarterly) | -252.6% |
| Return on Net Operating Assets | -169.0% |